Understanding White Patches on Skin

During clinical evaluation, a dermatologist examines lesion morphology, border demarcation, surface texture, and optical characteristics under Wood's lamp examination and polarized dermoscopy. Vitiligo presents as complete depigmentation (enamel, milky-white macules) with sharply defined margins, a completely smooth surface, and occasionally leukotrichia (white hair follicles), demonstrating intense chalky-white accentuation under Wood's light due to total melanocyte loss. In contrast, Tinea Versicolor (Pityriasis Versicolor) is a superficial Malassezia fungal overgrowth characterized by hypopigmented or light-brown macules on the upper trunk with fine furfuraceous scaling (a positive scratch sign) and golden-yellow or pale green fluorescence. Pityriasis Alba, commonly observed in atopic children, presents as ill-defined, faintly hypopigmented patches on the face or arms with subtle surface dryness (xerosis) that do not exhibit stark chalky contrast under Wood's lamp.

Vitiligo is an autoimmune dermatosis where cytotoxic CD8+ T-lymphocytes selectively target and destroy epidermal melanocytes. Medical therapy focuses on halting this inflammatory cascade and awakening dormant pigment reserves. Topical calcineurin inhibitors (such as tacrolimus and pimecrolimus) suppress localized cytokine release (including interferon-gamma) without causing epidermal atrophy, making them safe for long-term facial and intertriginous use. Targeted Narrowband UVB (NB-UVB, 311 nm) phototherapy operates synergistically: it induces local immunosuppression and T-cell apoptosis while simultaneously stimulating quiescent amelanotic melanocyte stem cells in the hair follicle outer root sheath. These stimulated melanocytes proliferate, synthesize melanin, and migrate outward into the depigmented epidermis, yielding characteristic islands of perifollicular repigmentation.

Over-the-counter creams frequently contain high-potency fluorinated steroids (such as clobetasol propionate) combined indiscriminately with antibiotics and antifungals. Applying unsupervised steroids to undiagnosed white patches causes cutaneous adverse reactions, including epidermal thinning (atrophy), telangiectasias, striae, and steroid rosacea. If the patch is caused by a fungal infection like Tinea Versicolor, topical steroids suppress local cellular immunity, leading to 'Tinea Incognito'—an exacerbated, atypical, and widespread fungal infection that is significantly more difficult to manage. Furthermore, prolonged steroid abuse can alter pigmentary borders, mask crucial diagnostic features, and trigger rebound hypopigmentation, severely compromising professional dermatological treatment.

Vitiligo is clinically categorized into active (unstable) and stable forms. Surgical intervention is strictly indicated only for stable vitiligo, defined as having no new white patches, no enlargement of existing lesions, and no Koebner phenomenon (pigmentation loss induced by minor trauma, friction, or scratches) for a minimum of 12 consecutive months. When stable patches fail to repigment under medical and phototherapy regimens due to depleted follicular melanocyte reservoirs—frequently observed on bony prominences or in segmental vitiligo—surgical grafting is deployed. Techniques include Suction Blister Epidermal Grafting (SBEG), which transfers an ultrathin epidermal graft containing healthy melanocytes onto a deepithelialized recipient bed, and Melanocyte-Keratinocyte Cell Suspension (MKCS), where harvested cell suspensions repigment larger anatomical areas with excellent color matching.